Caris Life Sciences: The Quiet Founder Trying to Win the Holy Grail of Oncology
Caris Life Sciences, CAI, uses AI-trained molecular oncology data for therapy selection and multi-cancer early detection, with 97% of…
NASDAQ
Caris Life Sciences, Inc.
CAI
1 article
$7.2B Market cap · 2026-09-01
